RxDoctor Payments Data

Lynda Hughes

Nurse Practitioner · Dyersburg, TNNPI 1861487282

Payments from drug & device makers

$684in general payments, 2019–2025

Across 35 payments — averaging $19.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$171
  • Lilly USA, LLC$117
  • Novo Nordisk$80
  • Amgen$75
  • Takeda Pharmaceuticals U.S.A., Inc.$57
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$39
  • plus $145 from 5 others

What the payments were for

  • Food & beverage$684100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$684 in reported general payments places this provider in the 65th percentile of 2,662 nurse practitioner providers in Tennessee.

See all nurse practitioner providers in Tennessee

Medicare billing

Part B allowed, 2024
$73,590
Medicare patients
150
Services billed
6,300

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide127$126,177
LinzessLinaclotide105$62,500
MounjaroTirzepatide44$43,789
EliquisApixaban61$40,131
VraylarCariprazine Hcl27$38,406
FarxigaDapagliflozin Propanediol55$36,371
JanuviaSitagliptin Phosphate31$24,679
JardianceEmpagliflozin34$22,601
TrulicityDulaglutide19$20,044
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$19,142
EntrestoSacubitril/Valsartan24$16,138
GemtesaVibegron15$14,921
TrintellixVortioxetine Hydrobromide16$14,166
BrilintaTicagrelor28$13,359
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen768$12,904

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$80$126,177127 claims
AbbVieLinzess, Vraylar$171$100,905132 claims
Lilly USA, LLCMounjaro, Trulicity$117$63,83463 claims
AstraZenecaFarxiga, Brilinta, Symbicort$30$52,48095 claims
PfizerEliquis$27$40,13161 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$57$14,16616 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,662 nurse practitioner providers in Tennessee.

Other nurse practitioner in Dyersburg

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →